77 related articles for article (PubMed ID: 9673417)
1. 2-Deoxy-D-[1-3H]glucose uptake by MCF7 and T47D breast tumour cells under conditions of active proliferation and serum deprivation.
Smith TA; Title JC; Eccles SA; McCready VR
Anticancer Res; 1998; 18(3A):1865-9. PubMed ID: 9673417
[TBL] [Abstract][Full Text] [Related]
2. Treatment of SW620 cells with Tomudex and oxaliplatin induces changes in 2-deoxy-D-glucose incorporation associated with modifications in glucose transport.
Smith TA; Maisey NR; Titley JC; Jackson LE; Leach MO; Ronen SM
J Nucl Med; 2000 Oct; 41(10):1753-9. PubMed ID: 11038008
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth factors on proliferation of normal, borderline, and malignant breast epithelial cells.
Bhalla V; Joshi K; Vohra H; Singh G; Ganguly NK
Exp Mol Pathol; 2000 Apr; 68(2):124-32. PubMed ID: 10716915
[TBL] [Abstract][Full Text] [Related]
4. Proliferation is associated with 2-deoxy-D-[1-3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells.
Smith TA; Titley JC; McCready VR
Nucl Med Biol; 1998 Jul; 25(5):481-5. PubMed ID: 9720666
[TBL] [Abstract][Full Text] [Related]
5. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-Induced increase in FDG uptake in MCF7 cells.
Burgman P; Odonoghue JA; Humm JL; Ling CC
J Nucl Med; 2001 Jan; 42(1):170-5. PubMed ID: 11197971
[TBL] [Abstract][Full Text] [Related]
7. Reversible alterations in the mitotic cycle of chick embryo cells in various states of growth regulation.
Rubin H; Steiner R
J Cell Physiol; 1975 Apr; 85(2 Pt 1):261-70. PubMed ID: 235556
[TBL] [Abstract][Full Text] [Related]
8. Effect of glucose uptake on growth rate of mouse 3T3 cells.
Romano AH; Connell ND
J Cell Physiol; 1982 May; 111(2):195-200. PubMed ID: 7085776
[TBL] [Abstract][Full Text] [Related]
9. S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct.
Beissel B; Silva ID; Pesquero JB; Russo J; Schor N; Bellini MH
Oncol Rep; 2007 Mar; 17(3):611-5. PubMed ID: 17273741
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
[TBL] [Abstract][Full Text] [Related]
11. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
12. The proliferative effects of 5-androstene-3 beta,17 beta-diol and 5 alpha-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines.
Aspinall SR; Stamp S; Davison A; Shenton BK; Lennard TW
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):37-51. PubMed ID: 15026082
[TBL] [Abstract][Full Text] [Related]
13. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
Higashi K; Clavo AC; Wahl RL
J Nucl Med; 1993 Mar; 34(3):414-9. PubMed ID: 8441032
[TBL] [Abstract][Full Text] [Related]
14. AP-1 blockade inhibits the growth of normal and malignant breast cells.
Ludes-Meyers JH; Liu Y; Muñoz-Medellin D; Hilsenbeck SG; Brown PH
Oncogene; 2001 May; 20(22):2771-80. PubMed ID: 11420689
[TBL] [Abstract][Full Text] [Related]
15. Transport of 6-deoxy-D-glucose and D-xylose by untransformed and SV40-transformed 3T3 cells.
Romano AH; Connell ND
J Cell Physiol; 1982 Apr; 111(1):83-8. PubMed ID: 6282906
[TBL] [Abstract][Full Text] [Related]
16. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
17. Adenosine stimulation of proliferation of breast carcinoma cell lines: evaluation of the [3H]thymidine assay system and modulatory effects of the cellular microenvironment in vitro.
Mujoomdar M; Bennett A; Hoskin D; Blay J
J Cell Physiol; 2004 Dec; 201(3):429-38. PubMed ID: 15389546
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
19. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.
Jansson A; Gunnarsson C; Stål O
Endocr Relat Cancer; 2006 Sep; 13(3):875-84. PubMed ID: 16954436
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
